Lawsuit Overview
Oct. 25, 2013 (Update) - The case was dismissed. Feb. 12, 2013 (Shareholders Foundation) -- An investor in shares of BioClinica Inc (NASDAQ:BIOC) filed a lawsuit to halt the proposed takeover of BioClinica Inc by JLL Partners, Inc at $7.25 per NASDAQ:BIOC share. On Jan. 30, 2013, BioClinica, Inc. (NASDAQ: BIOC) announced that it has entered into an agreement to be acquired by a hold...
You must register (for free) or login to view the entire case.